Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

SeraCare™ ACCURUN™ 676 Cystic Fibrosis Extended Control

A synthetic, multiplex control formulated for research use in laboratory testing, molecular screening, and mutation testing, with assays that identify mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene

Manufacturer:  SeraCare™ 20400009

Catalog No. 22-554-480

Add to cart



  • Eliminates errors arising from use of rotating gDNA control schemes with incomplete mutation profiles
  • Controls contain a mixture of oligonucleotides that produce a call for every mutation tested
  • ACCURUN 676 covers 34 mutations, and when used in conjunction with ACCURUN 644, covers all 81 mutations in the Prima xTAG™ CFTR 70+6 Assay
  • All mutations contained in a single vial
  • High purity, large lots, stable materials–no additional processing required

Not for use in diagnostic procedures



Detects significant errors with the use of rotating gDNA control schemes, research use only
ACCURUN™ 676 Cystic Fibrosis Extended Control
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit